FDC Limited (NSE:FDC)
464.95
-4.55 (-0.97%)
Aug 26, 2025, 3:29 PM IST
FDC Limited Revenue
FDC Limited had revenue of 6.48B INR in the quarter ending June 30, 2025, with 1.59% growth. This brings the company's revenue in the last twelve months to 21.18B, up 3.59% year-over-year. In the fiscal year ending March 31, 2025, FDC Limited had annual revenue of 21.08B with 8.50% growth.
Revenue (ttm)
21.18B
Revenue Growth
+3.59%
P/S Ratio
3.54
Revenue / Employee
3.18M
Employees
6,659
Market Cap
75.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 21.08B | 1.65B | 8.50% |
Mar 31, 2024 | 19.43B | 1.59B | 8.92% |
Mar 31, 2023 | 17.84B | 2.56B | 16.74% |
Mar 31, 2022 | 15.28B | 1.95B | 14.61% |
Mar 31, 2021 | 13.33B | -109.88M | -0.82% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
FDC Limited News
- 3 months ago - FDC shares drop over 3% as Q4 EBITDA falls 4.2% YoY to Rs 54 crore, net profit down 16.4% YoY - Business Upturn
- 9 months ago - FDC receives US FDA approval for Cefixime 400 mg tablets - Business Upturn
- 1 year ago - FDC shares surge 11%, leading gains in BSE Healthcare index - Business Upturn